Transformative Shifts Underway in the animal vaccines market
- shubham3872
- Oct 16
- 3 min read
Market Overview
The animal vaccines market size was valued at USD 14.51 billion in 2024, exhibiting a CAGR of 9.7% during 2025–2034.
Animal vaccines are essential tools in preventing infectious diseases in animals, thereby safeguarding public health and ensuring food security. These vaccines are administered to livestock, poultry, and companion animals to stimulate the immune system without causing the disease itself. The global emphasis on disease prevention, coupled with the increasing adoption of veterinary care, is propelling the demand for animal vaccines.
Market Scope
Product Segmentation: The animal vaccines market encompasses various types of vaccines, including attenuated live vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, recombinant vaccines, and DNA vaccines. Among these, attenuated live vaccines held the largest market share in 2024, owing to their efficacy and cost-effectiveness
Application Areas: Animal vaccines are utilized across several application areas, such as livestock, poultry, and companion animals. The livestock segment is anticipated to dominate the market, driven by the growing demand for meat and dairy products globally.
Route of Administration: Vaccines are administered through various routes, including intramuscular, subcutaneous, and oral methods. The choice of administration route depends on factors like the type of vaccine and the species being vaccinated.
End-User Segmentation: Veterinary hospitals and clinics are the primary end-users of animal vaccines, providing vaccination services to pet owners and livestock farmers. The increasing number of veterinary establishments is contributing to the market's growth.
Market Opportunities
Advancements in Vaccine Technologies: The development of novel vaccine platforms, such as mRNA vaccines, offers opportunities for more effective and rapid responses to emerging infectious diseases in animals
Rising Pet Ownership: The growing trend of pet adoption, particularly in urban areas, is driving the demand for vaccines for companion animals, presenting a lucrative opportunity for market players.
Government Initiatives: Governments worldwide are implementing policies to promote animal health, including vaccination programs and subsidies, thereby creating a favorable environment for market expansion.
Emerging Markets: Developing regions, including parts of Asia and Africa, are witnessing increased investments in veterinary healthcare infrastructure, opening new avenues for market growth.
Browse Full Insights:
Regional Analysis
North America: Dominating the global animal vaccines market, North America accounted for over 27% of the market share in 2024. The region's strong veterinary healthcare infrastructure and high pet ownership rates contribute to its leading position
Europe: Europe is also a significant market for animal vaccines, with countries like France and Germany actively implementing vaccination programs to control diseases such as bluetongue
Asia-Pacific: The Asia-Pacific region is expected to witness the fastest growth in the animal vaccines market, driven by the large livestock population in countries like China and India, as well as increasing awareness about animal health.
Latin America and Middle East & Africa: These regions are gradually adopting animal vaccination programs, with Brazil leading efforts in poultry vaccination to combat avian influenza outbreaks
Key Companies
Zoetis Inc.
Merck & Co., Inc. (Merck Animal Health)
Boehringer Ingelheim International GmbH
Elanco Animal Health Incorporated
Ceva Santé Animale
Virbac
Phibro Animal Health Corporation
HIPRA
Dechra Pharmaceuticals PLC
Vetoquinol S.A.
Biogenesis Bago
Indian Immunologicals Limited
Neogen Corporation
IDT Biologika GmbH
Hester Biosciences Limited
Conclusion
The global Animal Vaccines market is on a robust growth trajectory, fueled by technological advancements, increasing awareness of animal health, and supportive government initiatives. As the demand for effective disease prevention and control measures rises, the market presents significant opportunities for stakeholders to contribute to the enhancement of animal health and public safety.
More Trending Latest Reports By Polaris Market Research:
Comments